Kidney international reports · 2026
KDIGO Workshop Report on the Implementation and Expansion of Home Hemodialysis in East Asia: A Focus on Hong Kong, Japan, Korea, and Taiwan.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Masakane Ikuto, Bennett Paul N, Chao Chia-Ter, Cheung Michael, Furuzono Tsutomu, Hara Masaki, Hsu Yung-Ho, Huang Chiu-Ching, Ishigaki Sayaka, Jadoul Michel, Kang Eunjeong, Kim Seong Geun, Kokubo Kenichi, Komaba Hirotaka, Kuo Huey-Liang, Kwon Ki Jeong, Kwong Vickie, Lau Wai-Yan, Lau Titus, Lee Dong Hyung, Li Philip Kam-Tao, Marshall Mark, Mitra Sandip, Nagai Kojiro, Ogawa Tomonari, Park Hyeong Cheon, Poon Clara, Tsuji Naoko, Wong Joseph, Wong Po Kwan, Wong Sunny, Wu Hung-Lai, Wu Mei-Yi, Yoo Kyung Don, Chan Christopher
Аннотация
Home hemodialysis (HHD) is associated with greater patient autonomy and treatment satisfaction compared with in-center kidney replacement modalities, yet the level of HHD use is low, particularly in the East Asian region. Reasons for limited HHD use are a strong in-center hemodialysis (ICHD) culture, hospital-based infrastructure, regulatory barriers, limited knowledge among dialysis clinicians, home resource requirements, and patient-related fears regarding self-management. To redress the low HHD uptake in East Asia, a 1-day Kidney Disease: Improving Global Outcomes (KDIGO) workshop of key nephrology stakeholders, nephrologists, nurses, and individuals receiving HHD from East Asia was held in September 2025 in Kawagoe, Japan. The goals were to create a strategic framework and a roadmap for expanding HHD in key East Asian countries. This report details the workshop content and provides a roadmap for stakeholders to move forward, with the aim to increase the therapeutic options for people with kidney failure.